In 1997 the FDA approved Boston Scientific Corporation's ProteGen Sling for the treatment of feminine urinary stress incontinence. The ProteGen Sling is implanted to provide bladder support.

In 1999 Boston Scientific recalled all unused ProteGen Slings because of evidence that the device may cause damage including, but not limited to, harm to the vaginal wall, dehiscence (splitting of the tissue), infection, vaginal discharge, vaginal bleeding, and odor. While the company did not recall previously implanted ProteGen Slings, women who have received the device should seek medical attention.

See your doctor if you have experienced serious side effects after receiving the ProteGen Sling. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.



See Also

  1. Bladder Control & Urinary Incontinence Devices: Overview
  2. Vaginal Abnormalities & Conditions: Overview
  Name Size